Optibrium and BioPharmics Enter Partnership on Computational Drug Design
Industry-leading 3D ligand-based design approaches from BioPharmics will be available in StarDrop, Optibrium’s small molecule design and optimisation software. CAMBRIDGE, CAMBRIDGESHIRE, UNITED KINGDOM, May 20, 2021 /EINPresswire.com/ -- Optibrium Ltd …